Northwestern Mutual Wealth Management’s Elevation Oncology ELEV Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-133	Closed	-$49	–	3873
2025 Q2	$49	Buy	+133	New	+$44	﹤0.01%	3581

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Northwestern Mutual Wealth Management's ELEV Position: Q3 2025 in Review

Northwestern Mutual Wealth Management sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 133 shares — an estimated $49 sold.

Northwestern Mutual Wealth Management first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $49 in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Northwestern Mutual Wealth Management reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 133 Elevation Oncology shares in Q3 2025, an estimated $49.
Northwestern Mutual Wealth Management first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Northwestern Mutual Wealth Management's Elevation Oncology position peaked at $49 in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.